Abstract
Survival and proliferation of cell cultures from human anaplastic astrocytomas were shown to be enhanced by glucocorticoids with an optimal concentration of approximately 2.5 x 10(-5)M (10 micrograms/ml). The stimulation of proliferation was only observed in a clonal growth assay and was reversed as the size of individual colonies reached approximately 50 cells. Above this size, and in regular monolayer cultures, glucocorticoids were found to inhibit cell proliferation as measured by direct cell counting and incorporation of [3H] thymidine. Cultures grown to maximum cell densities in non-limiting medium conditions reached a lower terminal cell density, and had a reduced labelling index with [3H] thymidine in the presence of glucocorticoids. Although there was little difference between the actions of beta-methasone, dexamethasone and ethyl prednisolone, methyl prednisolone was found to be more effective, both in terms of stimulation of clonal growth and inhibition of growth at high cell densities. There was no evidence of cytotoxicity with glucocorticoids up to 5 x 10(-5)M (20 micrograms/ml) and it is suggested that glucocorticoids act via a normal regulatory process, perhaps enhancing cell-cell recognition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Freshney, R., Sherry, A., Hassanzadah, M. et al. Control of cell proliferation in human glioma by glucocorticoids. Br J Cancer 41, 857–866 (1980). https://doi.org/10.1038/bjc.1980.161
Issue Date:
DOI: https://doi.org/10.1038/bjc.1980.161
This article is cited by
-
Treating gliomas with glucocorticoids: from bedside to bench
Acta Neuropathologica (2006)
-
Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain
Journal of Neuro-Oncology (1988)
-
Glucocorticoid receptors in glioblastoma multiforme: A new approach to antineoplastic glucocorticoid therapy
Acta Neurochirurgica (1988)